Answer: It is not more expensive
Look for color change, clumping, or cloudiness (lyophilized) or cloudiness, particles, or color change (reconstituted)
This should explain: The therapy isn't FDA approved Possible risks and lack of proven benefits Other treatment options How often they'll check in Who to contact with questions Use everyday language
The combination of BPC-157 and TB-500 addresses all phases of surgical wound healing through their complementary mechanisms
is a sterile solution developed by Bioaxa, designed for intramuscular (IM) or intravenous (IV) administration
Specifically, BPC-157 treated rats exhibited faster axonal regeneration, improved presentation of neural fascicles, a homogeneous regeneration pattern (indicating organized rather than chaotic regrowth), increased density and size of regenerative fibers, and evidence of both epineural and perineural regeneration